Datopotamab deruxtecan (Dato-DXd) in patients with endometrial (EC) or ovarian cancer (OC): Results from the phase II TROPION-PanTumor03 study Meeting Abstract
| Authors: | Oaknin, A.; Ang, J. E.; Rha, S. Y.; Yonemori, K.; Kristeleit, R.; Lin, C. C.; Satoh, T.; Garcia, P. E.; Sendur, M. A. N.; Rodríguez, L. M.; Italiano, A.; Lugowska, I.; Ray-Coquard, I. L.; Oza, A. M.; Zhao, J. L.; Gajavelli, S.; Filant, J.; Bodla, S.; Janjigian, Y. Y.; Meric-Bernstam, F. |
| Abstract Title: | Datopotamab deruxtecan (Dato-DXd) in patients with endometrial (EC) or ovarian cancer (OC): Results from the phase II TROPION-PanTumor03 study |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | S547 |
| End Page: | S548 |
| Language: | English |
| ACCESSION: | WOS:001326612901021 |
| DOI: | 10.1016/j.annonc.2024.08.776 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 714MO -- Source: Wos |
